on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group Discloses Position in Spire Healthcare
The Vanguard Group, Inc. has disclosed its position concerning Spire Healthcare Group plc on the 3rd of June, 2026. The disclosure, submitted under Rule 8.3 of the Takeover Code, reveals Vanguard's significant interest in Spire, indicating ownership of 14,482,212 ordinary shares, equating to 3.60% of the company's relevant securities.
The disclosure report confirms there have been recent transactions, specifically the sale of 2,206 shares at a price of 2.17 GBP per share. Currently, there are no cash-settled or stock-settled derivatives associated with this disclosure, emphasizing a straightforward stake in Spire Healthcare Group.
No additional agreements, arrangements, or understandings concerning options or derivatives linking Vanguard to Spire or any other party have been noted, confirming the stand-alone nature of the disclosed interests.
R. E.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news